Tan Lee Meng
Non-Executive Chairman
Appointed 22 May 2017. Member of Audit, Remuneration and Nominating Committees.The business, the people and the ownership behind Medinex.
Business overview
Medinex Limited is a Singapore-based medical support services provider. It helps clinics with setup, licensing, accounting, tax, human resources and corporate secretarial services, and procures medical and pharmaceutical products. It also provides business support services to clients outside healthcare. Its medical services segment was discontinued with effect from 31 March 2026 following the disposal of Express Medical.
Listed security
Board & management
Five issuer Board directors, four other key management people and two joint secretaries, with Chai Yee Hoi counted once for his combined roles. No current CFO or extra operating-director Board seat inferred. Annual appointment dates and later AGM re-elections are separately dated.
Non-Executive Chairman
Appointed 22 May 2017. Member of Audit, Remuneration and Nominating Committees.Executive Director and Chief Executive Officer
Appointed 1 June 2017; overall management, strategy and business development.Lead Independent Non-Executive Director
Appointed 14 November 2018. Audit Chairman; Remuneration and Nominating member.Independent Non-Executive Director
Appointed 1 September 2020. Remuneration Chairman; Audit and Nominating member.Independent Non-Executive Director
Appointed 23 August 2021. Nominating Chairman; Audit and Remuneration member.Chief Operating Officer
Group long-term strategy and Nex Healthcare operations; not an issuer Board member.Financial Controller
Re-appointed Financial Controller from 16 January 2024; former Chief Integration Officer from June 2022. Group finance and accounting. No current CFO title is invented.Chief Tax Officer; Joint Company Secretary
Business support tax advisory and AccTax director. Also one of two joint Company Secretaries; one person with combined roles, not issuer Board.Chief Business Development Officer
Also Managing Director of Ark Leadership & Learning and director of MDX Advisory and Carlin. Register name Low Mui Keow, Valerie (Lu Meijiao, Valerie); not an issuer Board member.Joint Company Secretary
Other joint Company Secretary; not an issuer Board member.Tan Lee Meng and Jessie Low Mui Choo re-elected; Forvis Mazars LLP re-appointed
All resolutions passed. Re-election is not a new appointment. AGM minutes list Wong Zi En as the attending audit partner; annual report is signed by engagement partner Lok Yung Hui. As reported at 2026-07-24Roles listed in Annual Report 2026; current appointments are not independently verified.
Holdings
Twenty registered accounts, ten substantial-holder rows, eleven register contexts and three separately dated interest changes. Annual footnote account-name discrepancy retained explicitly. Direct and deemed interests overlap. Jessie August acquisition updates her interest without rewriting June register. Readable Form1/Form3 companions are used, not XFA placeholders.
0.29%Total interest
6.45%Total interest
9.26%Total interest
9.26%Total interest
Direct 12,460,110 shares; 9.26%; deemed – shares; –%
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-1522.35%Total interest
22.35%Total interest
6.45%Total interest
6.45%Total interest
6.45%Total interest
134,543,843 shares
One vote per ordinary share; not the EPS weighted denominator. As reported at 2026-06-15No treasury shares or subsidiary holdings
Express register statement as at 15 June 2026. As reported at 2026-06-15236 holders
Distribution bands sum to the stated total. As reported at 2026-06-1560 / 12,600 / 341,900 / 23,359,040 / 110,830,243 shares
1 / 23 / 53 / 144 / 15 holders respectively; exact denominator 134,543,843 shares. As reported at 2026-06-1585.53%Total interest
Approximately 28.29%
Issuer-stated float; unknown nominee ownership is not inferred. As reported at 2026-06-1528,543,140 direct shares; 390,000 deemed shares
Footnote (1) says 13,269,000 in Hong Leong Finance Nominees and 15,274,140 in Citibank Nominees. The preceding top20 instead lists 15,274,140 under Jessie herself and only 1,059,400 under Citibank. Preserve both original disclosures; no reassignment or correction inferred. As reported at 2026-06-15390,000 shares
Spouse Karunanithi S/O Letchumanan; overlaps the deemed interest already shown, not extra shares. As reported at 2026-06-1566.67% / 37.50% / 25.00% / 37.50%
Tan Lee Meng holds 66.67% Shine Medi-Capital, which holds 37.50% Shinex; Sia Ling Sing holds 25.00% and Lim Ewe Ghee 37.50% Shinex. Their deemed issuer shares overlap Shinex direct 8,674,460. As reported at 2026-06-1540.0% / 40.0%
Both hold 40.0% of HSN Healthcare; the same 12,460,110 issuer shares are attributed as deemed interests, not extra shares. As reported at 2026-06-1541.72% / 22.66%
Approximate respective HCSS ownership. Each deemed issuer holding is the same 30,071,050 directly held by HCSS. As reported at 2026-06-1521.8%Total interest
15.46%Total interest
680,500 direct shares; 0.51%; deemed 0 shares; total 680,500 shares
Disposed his 66.67% Shine Medi-Capital holding and ceased 8,674,460 deemed issuer shares. Retained direct issuer shares; cessation of substantial status is not sale of all issuer shares. Distinct from director Tan Lee Meng. As reported at 2026-05-21Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-06-15 · PDF p. 95
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| HC SURGICAL SPECIALISTS LIMITED | 30,071,050 shares; 22.35% | PDF p. 952026-06-15 | |
| JESSIE LOW MUI CHOO | 15,274,140 shares; 11.35% | PDF p. 952026-06-15 | |
| HONG LEONG FINANCE NOMINEES PTE LTD | 13,269,000 shares; 9.86% | PDF p. 952026-06-15 | |
| HSN HEALTHCARE PTE. LTD. | 12,460,110 shares; 9.26% | PDF p. 952026-06-15 | |
| BNP PARIBAS NOMINEES SINGAPORE PTE LTD | 12,122,040 shares; 9.01% | PDF p. 952026-06-15 | |
| SHINEX CAPITAL PTE LTD | 8,674,460 shares; 6.45% | PDF p. 952026-06-15 | |
| DBS NOMINEES PTE LTD | 6,808,287 shares; 5.06% | PDF p. 952026-06-15 | |
| LEO TING PING RONALD | 2,000,000 shares; 1.49% | PDF p. 952026-06-15 | |
| CHAI YEE HOI | 1,698,120 shares; 1.26% | PDF p. 952026-06-15 | |
| KOH SEW LEAN | 1,610,000 shares; 1.20% | PDF p. 952026-06-15 | |
| CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD. | 1,600,000 shares; 1.19% | PDF p. 952026-06-15 | |
| NG HOCK KON | 1,500,000 shares; 1.11% | PDF p. 952026-06-15 | |
| LOW MUI KEOW, VALERIE (LU MEIJIAO, VALERIE) | 1,483,636 shares; 1.10% | PDF p. 952026-06-15 | |
| NOVUS CORPORATE FINANCE PTE. LTD. | 1,200,000 shares; 0.89% | PDF p. 952026-06-15 | |
| CITIBANK NOMINEES SINGAPORE PTE LTD | 1,059,400 shares; 0.79% | PDF p. 952026-06-15 | |
| TEOU KEM ENG @TEOU KIM ENG | 900,000 shares; 0.67% | PDF p. 952026-06-15 | |
| JITENDRA KUMAR SEN | 866,500 shares; 0.64% | PDF p. 952026-06-15 | |
| PHILLIP SECURITIES PTE LTD | 861,000 shares; 0.64% | PDF p. 952026-06-15 | |
| WAYNE KOO KIM HENG (WAYNE QIU JINXING) | 829,060 shares; 0.62% | PDF p. 952026-06-15 | |
| JEREMY LEE SHENG POH | 800,000 shares; 0.59% | PDF p. 952026-06-15 | |
Group structure
Nine current wholly owned directly held subsidiaries; Express Medical disposed 31 March 2026; former Sen Med struck off per dated official announcement, with contradictory annual Note15 retained explicitly. Two explicitly classified joint ventures at effective 20%, including Malaysian entity held through HEPL. MDX Professional Services formerly Medinex Professional Services, not two companies. Carlin settlement separates new issuance, existing treasury transfer and cash repurchase cost.
| Company | Market | Ownership interest |
|---|---|---|
| Medinex Corporate Services Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services | |
| Medinex Healthcare Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Medical support services | |
| Nex Healthcare Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Medical support services and pharmaceutical services | |
| Acctax Management Consultancy Private LimitedNote15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services | |
| MDX Professional Services Pte. Ltd. (f.k.a. Medinex Professional Services Pte. Ltd.)Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services | |
| Ark Leadership & Learning Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Human resources consultancy and learning development services | |
| MDX Advisory Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services | |
| Medinex Corporate Services Sdn. Bhd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Malaysia; Group ownership 2026/2025 100/100%; NCI –/–%; Shared service centre | |
| Carlin Management Services Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services | |
| Express Medical Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained. Former 55%-owned subsidiary disposed on 31 March 2026; no longer held at year-end. S$100,000 cash consideration, gain S$17,180 and net cash inflow S$78,211. Not a current subsidiary.PDF p. 742026-03-31 | Singapore; Group ownership 2026/2025 –/55%; NCI –/45%; Operation of medical clinic and the provision of medical services | |
| Sen Med Holdings Pte. Ltd.Official 30 May 2025 Rule706A announcement and current group chart agree on 29 May 2025. Current Note15 p75 instead says fully dissolved 29 May 2026 and describes voluntary liquidation. Preserve this source date/procedure discrepancy; not current subsidiary.PDF p. 12025-05-29 | Former 55%-owned subsidiary; struck off 29 May 2025 | |
| Carlin Management Services Pte. Ltd. — deferred consideration settled100% acquisition completed 1 April 2022. Deferred S$600,000 consideration settled on 11 December 2025: 2,666,667 shares in total, including existing treasury shares. New shares expected listed 15 December, distinct from allotment date. Treasury transfer announcement values transferred shares at issue price S$183,150; cash repurchase cost S$185,078 is a different measure.PDF p. 12025-12-11 | 1,852,667 new shares; 814,000 treasury shares; S$0.225 per share | |
| Healthcare Essentials Pte. Ltd. (“HEPL”)Note16 explicit joint-control conclusion; held by Company directly. Effective 20% is stated, not multiplied again. Malaysian entity new in FY2026, prior-year dash is retained.PDF p. 772026-03-31 | Singapore; effective Group equity 2026/2025 20/20%; Distribution of medical consumables | |
| Healthcare Essentials Sdn. Bhd. (“HESB”)Note16 explicit joint-control conclusion; held by Healthcare Essentials Pte. Ltd.. Effective 20% is stated, not multiplied again. Malaysian entity new in FY2026, prior-year dash is retained.PDF p. 772026-03-31 | Malaysia; effective Group equity 2026/2025 20/–%; Distribution of medical consumables | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Lin Moi Heyang | Company Secretary | Key management | PDF p. 99 |
Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Interested Person Transactions | The Company did not enter into any interested person transactions with a value of S$100,000 or more in FY2026. | Company, FY2026 | PDF p. 43 |
| Service rendered fee | 21,584 $ | Group 2026 (with related parties*; entities where a director has beneficial interests); 2025 comparative 28,279 | PDF p. 86 |
| Management fee income | 4,000,000 $ | Company 2026, with subsidiaries; 2025 comparative 3,800,000; Group columns – | PDF p. 86 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Financial guarantee | $5,000,000 | Company, corporate guarantees to banks for banking facilities of certain subsidiaries, 31 March 2026 (2025: $5,000,000) · As at 2026-03-31 | PDF p. 86 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Ms. Jessie Low Mui Choo | 339 S$’000 | FY2026 total, S$’000, Executive Director/CEO | PDF p. 38 |
| - directors’ fees | 106,250 $ | Group, directors of the Company, 2026 and 2025 (both 106,250) | PDF p. 86 |
| aggregate total remuneration for the top four (4) key management personnel | approximately S$791,000 | FY2026, top four key management personnel (not Directors or CEO) | PDF p. 38 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Workforce Diversity | 65 employees | Group, as of 31 March 2026 · As at 2026-03-31 | PDF p. 19 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| LOOKING AHEAD | We remain confident that these initiatives | Chairman and CEO message, FY2026 | PDF p. 5 |
Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.
Corporate information